scispace - formally typeset
G

Gil Mor

Researcher at Wayne State University

Publications -  350
Citations -  25442

Gil Mor is an academic researcher from Wayne State University. The author has contributed to research in topics: Trophoblast & Ovarian cancer. The author has an hindex of 86, co-authored 323 publications receiving 22062 citations. Previous affiliations of Gil Mor include Dartmouth College & Johns Hopkins University.

Papers
More filters
Journal ArticleDOI

The Immune System in Pregnancy: A Unique Complexity

TL;DR: The complexity of the immunology of pregnancy and the focus on the concept of immunology-of pregnancy as an organ transplantation have complicated the field and delayed the development of new guidelines with clinical implications that could help to answer these and other relevant questions as mentioned in this paper.
Journal ArticleDOI

Inflammation and pregnancy: the role of the immune system at the implantation site.

TL;DR: A new paradigm in terms of the fetal–maternal immune interaction as well as the immunological response of the mother to microorganism is proposed in order to better understand the immunology of pregnancy and to deliver the appropriate treatment to patients with pregnancy complications.
Journal ArticleDOI

The unique immunological and microbial aspects of pregnancy

TL;DR: Recent evidence that supports the idea that immunological responses at the receptive maternal–fetal interface are not simply suppressed but are instead highly dynamic is discussed.
Journal ArticleDOI

Comparison of statistical methods for classification of ovarian cancer using mass spectrometry data

TL;DR: This work compares the performance of several classes of statistical methods for the classification of cancer based on MS spectra and finds that RF outperforms other methods in the analysis of MS data.
Journal ArticleDOI

Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance.

TL;DR: The identification and cloning of human OCSCs can aid in the development of better therapeutic approaches for ovarian cancer patients and explain some of the unique characteristics of CSCs that control self-renewal and drive metastasis.